Q1 2023 Holdings
Filed 2023-05-15 | 75 holdings | $330.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $31.8K | 831,495 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $32.0K | 2,100,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $33.3K | 2,000,000 | 0.0% |
| Merus N V | COM | N5749R100 | $35.0K | 1,900,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $35.7K | 2,169,132 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $40.5K | 200,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $45.9K | 1,094,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $74.4K | 2,000,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $88.1K | 3,421,541 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $101.5K | 4,684,264 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $103.6K | 6,448,359 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $104.0K | 1,576,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $106.8K | 775,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $111.8K | 1,230,004 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $203.6K | 1,897,500 | 0.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.8M | 2,014,858 | 1.2% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $4.5M | 540,000 | 1.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.7M | 525,000 | 1.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $10.2M | 95,000 | 3.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $11.0M | 1,074,082 | 3.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $24.7M | 400,000 | 7.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $26.1M | 1,432,200 | 7.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $61.1M | 2,084,000 | 18.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $73.9M | 2,100,000 | 22.4% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $107.8M | 500,000 | 32.6% |